Dr. Robert Heuckeroth, M.D. Ph.D. is a Professor of Pediatrics and practicing pediatric gastroenterologist at The Children’s Hospital of Philadelphia- Research Institute. His research aims to better understand enteric nervous system anatomy and development to translate into clinical pathology. One of the diseases he studies is Hirschsprung’s disease, a disease in which the distal portion of the bowel is aganglionic due to defective nerve cell migration. This lack of nerve cells prevents the bowel from working correctly causing significant obstruction. Dr. Heuckeroth has provided insight into how the enteric nervous system develops and what external factors affect its development. Hirschsprung’s disease is commonly associated with RET mutations, as RET signaling is critical for enteric nervous system proliferation, migration, and network formation. Dr. Heuckeroth’s work has identified glial cell line-derived neurotrophic factor (GDNF) as an important molecule in establishing enteric nervous system structure and function. His lab has also identified external, prenatal factors that promote proper enteric nervous system development. Vitamin A is essential for enteric nervous system development. Additionally, they have shown that maternal usage of ibuprofen slows migration of enteric nervous system precursor cells and predisposes for Hirschsprung’s disease. They will continue to investigate the internal and external factors that contribute to enteric nervous system development with hopes of both preventing childhood bowel motility disorders.
Metabolomics and xenometabolomics: Applications to study metabolic health
Dr. Sean Adams is the Director of the Arkansas Children’s Nutrition Center where his research aims to understand the molecular processes that underlie metabolic disease and obesity. Although it is well known that health status affects the microbiome and that the microbiome affects health status, molecular signals linking gut microbes and host pathophysiology remain largely unknown. His lab applies metabolomics to gut microbiome metabolism, which they call xenometabolomics. During his talk, Dr. Adams focused on two topics. Firstly, how does microbial metabolism impact host physiology? To investigate this question, they have studied nitrogen, kidney, and liver metabolism in the context of an altered microbiome. They have found that dietary manipulation of the gut microbiome alters the host liver metabolome; there are reduced hepatic amino acids and urea cycle metabolites in mice feed a high starch diet. The same diet fed to experimental mice in a chronic kidney disease model ameliorates the kidney disease. They believe that the high starch diet increases the density of beneficial bacteria which then act as a nitrogen sink to reduce the nitrogen load on the kidney. Further, they reason that the changed metabolites from the changed microbiome reduces uremic solutes. Second, Dr. Adams discussed how host physiological states impact the microbe population and biochemistry. In a study of adult human women, they found that xenometabolites—specifically, cis-3,4-methylene heptanoyl carnitine and aminomalonic acid— change with both acute exercise and with weight loss. They have also found the microbiome and xenometabolomics distinctively change during diabetes progression in a rat model. In fact, performing a “xenoscan” of the cecal metabolites can discriminate severity of disease in a rat model. Knowing this, his group hopes to investigate how we can use these altered metabolites to treat or identify disease. In summary, Dr. Adam’s group has shown that host microbiome cross talk involves a two-way street. They will continue to investigate the molecular factors involved in this communication and work towards improving our metabolic health by studying microbiota ecology and xenometabolism.
Dr. Jenna McHenry, Assistant Professor of Psychology and Neuroscience at Duke University, starting Fall 2018
Hormonal regulation of a hypothalamic social reward circuit
Dr. Jenna McHenry was recently hired as an Assistant Professor of Psychology and Neuroscience at Duke University starting Fall 2018. She is currently completing her post-doctoral fellowship at the University of North Carolina- Chapel Hill in Dr. Garret Stuber’s laboratory. Her post-doctoral work has focused on investigating the neural circuitry that links social and emotional processing within the brain. As evident in reproductive mood disorders such as post-partum depression and premenstrual dysphoric disorder, hormonal flux can cause affective disorders. Dr. McHenry’s post-doctoral work has focused on studying the neural circuits—specifically the circuits involving the medial preoptic area (mPOA)— that regulate hormone mediated reward programming and sex specific behavior. In work published in Nature Neuroscience in 2017, Dr. McHenry used in vivo two-photon imaging in awake mice to identify a subset of neurotensin-expressing mPOA neurons that interface with the ventral tegmental area (VTA) to form a socially engaged reward circuit. By recording from these neurons both at different times in the female reproductive cycle and after ovariectomy, she found this subset of neurons is steroid-responsive, indicating steroids modulate social encoding. As an extension of her post-doctoral work, Dr. McHenry’s central research question in her laboratory will be to understand how social processing neurons are intertwined with or embedded into positive and negative valence systems. Further, her lab will investigate the interplay between social and non-social reward circuits. Her lab will use a combination of advanced techniques including freely moving calcium imaging and optogenetics to investigate these questions. We look forward to the exciting research that Dr. McHenry will bring to Duke as a new faculty member.
See Dr. McHenry’s work here.
“Microbiome-immune crosstalk in neurodevelopmental disease”
Dr. John Lukens is an Assistant Professor at the University of Virginia. His research aims to understand how immunologic pathways and interactions contribute to neurodevelopmental diseases. During his talk, he focused on his lab’s work related to the microbiome-immune crosstalk influencing autism and multiple sclerosis. Significant research exists implicating the microbiome in the pathogenesis of autism spectrum disorders. Dr. Lukens and his team found that microbiome differences between Jackson and Taconic mice change the TH17 response and the expression of an autistic phenotype. Further, they showed microbiota transfer of the maternal microbiome of susceptible, Taconic mice induces autism susceptibility in Jackson mice. They then asked what metabolites are affected by changes in the microbiome. They found that Taconic dam’s injected with Poly-IC have increased IL-17a compared to Jackson mice. Inhibiting IL-17 in pregnant dams rescued the mice from an autistic phenotype. Further work will investigate additional metabolic mediators and identify protective commensal bacteria. Dr. Lukens then shared his work on inflammasome biology, specifically with relation to experimental autoimmune encephalomyelitis (EAE), a mouse model for multiple sclerosis. Caspase 1 in inflammasomes is thought to be required to cleave IL-1β into active IL-1. However, research from the Lukens lab suggests inflammasome-independent cleavage of IL-1 is important in driving EAE. They found that reduced levels of IL-1 receptor correlate with a reduced disease burden; knocking out caspase 1 does not confer protection, but knocking out the IL-1 receptor does. Further research will seek to better define the pathways and pharmaceutical targets involved in this phenomenon.
Check out Dr. Lukens’s work here: Lukens Lab
Speaker: Dr. Anthony Blikslager, DVM, PhD, DACVS, from NC State
Title: “Do enteric glial cells play a role in age dependent mucosal repair?”
Summary: Dr. Anthony Blikslager is a Professor of Equine Surgery and Gastroenterology at NC State University. His lab’s focus is gastrointestinal physiology, specifically studying repair of the intestinal barrier and its role in healing in diseases like strangulating obstruction in animals and necrotizing enterocolitis in human newborns. In studying this intestinal barrier, Dr. Blikslager and his team found that prostaglandins stimulate the recovery of tight junctions in injured juvenile intestine. In the presence of a prostaglandin inhibitor, epithelial cells can repair but the tight junctions cannot, resulting in a leaky barrier. They also found an age dependence in barrier repair; younger mammals have greater difficult repairing their intestinal barrier. In newborns, epithelial restitution is arrested after ischemic injury. Using scanning electron microscopy, they have observed a different morphology in newborn and juvenile epithelial tissue. Neonatal epithelial tissue is rounded whereas juvenile tissue flattens out. The reason behind this remains unknown. To help answer this question, the lab has started to investigate the role of enteric glial cells in the healing process. They hypothesize that glial cells signal epithelial restitution. Further, they hypothesize that oligosaccharides feed the microbiota which in turns signals glial cells to support this restitution. Initial studies suggest that the enteric glial cell network is underdeveloped in neonates. Additionally, data show that feeding oligosaccharides results in both a maturation of the enteric glial cell network and a positive shift in the microbiome. These preliminary results suggest a temporal link to development of enteric glial cells, and define them as a potential target in intestinal barrier repair.
Speaker: Dr. Alban Gaultier, Ph.D. from University of Virginia
Title: “Effect of gut microbes on mood and anxiety”
Dr. Alban Gaultier is an Assistant Professor at the University of Virginia. To study the effect of the microbiome on depression and anxiety, Dr. Gaultier’s lab used the unpredictable chronic mild stress (UCMS) protocol to induce a depressive phenotype in mice. In work published in Scientific Reports this year, they showed the UCMS protocol does not change the total amount of microbiota present in the gut. Rather, it drives dysbiosis, reducing the population of Lactobacillus species in the gut across multiple strains of mice. Further, they found that replacing the lost species with Lactobacillus reuteri improved the depressive phenotype. They then delved into the pathogenesis of these findings.
Using metabolomics, they found an increase in products of the tryptophan kynurenine pathway in depressed mice. They reasoned that Lactobacillus generate reactive oxygen species, and these reactive species inhibit the enzyme IDO1, responsible for converting tryptophan to kynurenine. They hypothesized that reduced Lactobacillus species can cause increased levels of kynurenine, which is able to cross the blood brain barrier and contribute to depressive symptoms. To confirm this hypothesis, they found that augmenting kynurenine levels abolished the beneficial effect of Lactobacillus supplementation. Since the publication of their paper this year, Dr. Gaultier’s lab has been asking the question: how does the UCMS protocol change the microbiome?
Their first hypothesis was that the adaptive immune system could be contributing to this change, but they observed the same decrease in Lactobacillus in mice without an adaptive immune system. Further investigation showed that stressed mice have increased colonic motility; and because Lactobacillus are scavengers, they hypothesized that the reduced transit time in the colon caused the Lactobacillus to be outcompeted. Their data show that not only does administering a laxative reduce Lactobacillus species, but also it drives depressive behavior in mice.
Finally, they have been investigating the effect of the kynurenine pathway on oligodendrocytes, the glial cells of the CNS, as a reduction of glial cells can be found in the brains of depressed patients. Preliminary data shows that increased levels of kynurenine reduces the survival of oligodendrocyte progenitor cells and inhibits their differentiation. In summary, Dr. Gaultier and his lab has revealed a mechanism by which the microbiome, specifically Lactobacillus species, can contribute to anxiety and depression.
Speaker: Dr. Ivan de Araujo, D.Phil from Yale University
Dr. de Araujo is an Associate Professor from Yale University in the John B. Pierce Laboratory. The goal of his lab is to define the sensorimotor circuitry that controls feeding programs. In 2008 work published in Neuron, Dr. de Araujo showed that taste alone is not enough to communicate the reward value of sugar; he knocked out the trpm5 taste receptor in mice to create a taste blind mouse, but found that mice still tend to prefer sugar after a few hours.
From there, he studied the brain regions that encode for this reward. He found that reward behavior can be abolished by inhibiting the mesolimbic and nigrostriatal brain dopamine pathways. He found that intake of sweeteners activates the ventral striatum while D-glucose activates the dorsal striatum, and that the infusion of nutrients into the gut increases dopamine levels proportional to the amount of calories infused. He then went about delineating the neural circuit driving this response.
Initially, he found that energy is transmitted to the substantia nigra pars compacta to the dorsal striatum to the substantia nigra. Meanwhile, sweetness, in the form of non-nutritive sweeteners, takes a different pathway; it is transmitted to the ventral tegmental area to the ventral striatum to the ventral pallidum. In summary, Dr. Ivan de Araujo has greatly impacted the way we understand the neurobiology of feeding and the reward pathways it elicits.
Speaker: Dr. Adam Gracz, Ph.D from UNC Chapel Hill
Title: “Stem Cell Dynamics in Intestinal and Biliary Epithelia.”
Dr. Gracz is an Assistant Professor at UNC Chapel Hill and started his independent laboratory in July 2016 after completing his postdoctoral fellowship in intestinal stem cell biology in Dr. Scott Magness’s lab at UNC Chapel Hill. His collective work has explored how cells pattern to form functional tissues.
In his post-doctoral work, Dr. Gracz studied how stemness is regulated in the intestine. He and his colleagues found that SOX9 EGFP is expressed in variable levels in intestinal crypts, specifically finding that the level of expression marks distinct cell populations including progenitor cells, intestinal stem cells, and enteroendocrine cells. They used various novel and state-of-the-art techniques in their work; specifically, they collaborated with biomedical engineers to use microraft arrays (MRAs) to facilitate genetic screening of organoids. After his successful postdoctoral fellowship, Dr. Gracz started his independent laboratory based on the central question “How does epigenetic regulation drive functional outcomes in cell and tissue biology?”
His lab focuses on two areas of research: the chromatin structure of intestinal stem cell biology and the cellular dynamics of biliary epithelium. In his talk, Dr. Gracz focused on his lab’s work in biliary epithelial populations. He is using SOX9 EGFP to study the sub-populations of biliary epithelial cells and to identify potential biliary stem cells. In summary, Dr. Gracz is continuing to further the field’s understanding of stem cell dynamics in GI epithelial tissues.